Janssen presents positive Darzalex results at ASCO
The drug showed non-inferior efficacy and a significantly higher complete response rate in two different trials.
Read More
Tag: American Society of Clinical Oncology
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
